Drazen JM - Search Results

1

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.

Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. Chiang N, et al. Among authors: drazen jm. Pharmacol Rev. 2006 Sep;58(3):463-87. doi: 10.1124/pr.58.3.4. Pharmacol Rev. 2006. PMID: 16968948 Review.

2

International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.

Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T. Brink C, et al. Pharmacol Rev. 2003 Mar;55(1):195-227. doi: 10.1124/pr.55.1.8. Pharmacol Rev. 2003. PMID: 12615958 Review.

3

Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).

Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM, Serhan CN. Levy BD, et al. Among authors: drazen jm. Nat Med. 2002 Sep;8(9):1018-23. doi: 10.1038/nm748. Epub 2002 Aug 12. Nat Med. 2002. PMID: 12172542

4

Lipoxins and aspirin-triggered lipoxins in airway responses.

Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt B, Szczeklik W, Drazen JM, Serhan CN. Levy BD, et al. Among authors: drazen jm. Adv Exp Med Biol. 2003;525:19-23. doi: 10.1007/978-1-4419-9194-2_5. Adv Exp Med Biol. 2003. PMID: 12751730

5

International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions.

Bäck M, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. Bäck M, et al. Among authors: drazen jm. Pharmacol Rev. 2011 Sep;63(3):539-84. doi: 10.1124/pr.110.004184. Pharmacol Rev. 2011. PMID: 21771892 Review.

6

Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Bäck M, Powell WS, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. Bäck M, et al. Among authors: drazen jm. Br J Pharmacol. 2014 Aug;171(15):3551-74. doi: 10.1111/bph.12665. Epub 2014 Jul 12. Br J Pharmacol. 2014. PMID: 24588652 Free PMC article. Review.

7

International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor.

Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T. Brink C, et al. Pharmacol Rev. 2004 Mar;56(1):149-57. doi: 10.1124/pr.56.1.4. Pharmacol Rev. 2004. PMID: 15001665 Review.

8

Agonist-induced lipoxin A4 generation in vitro and in aspirin-sensitive asthmatics: detection by a novel lipoxin A4-ELISA.

Levy BD, Drazen JM, Serhan CN. Levy BD, et al. Among authors: drazen jm. Adv Exp Med Biol. 1997;400B:611-5. Adv Exp Med Biol. 1997. PMID: 9547611 Clinical Trial. No abstract available.

9

Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA.

Levy BD, Bertram S, Tai HH, Israel E, Fischer A, Drazen JM, Serhan CN. Levy BD, et al. Among authors: drazen jm. Lipids. 1993 Dec;28(12):1047-53. doi: 10.1007/BF02537069. Lipids. 1993. PMID: 8121246 Clinical Trial.

10

Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins.

Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, Serhan CN. Levy BD, et al. J Clin Invest. 1993 Sep;92(3):1572-9. doi: 10.1172/JCI116738. J Clin Invest. 1993. PMID: 8376607 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

681 results

Search Page